
E154 - (CME) The Efficacy and Safety of VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia
NEI Podcast
00:00
Dopamine Receptor Blocking
Not everyone develops persistent t d once you remove the anti psycotic or dopum receptor blocking agent. Some genetic vulnerability jeans that hadhav been identified. One day down the road, we might have really individualize treatment when we can figure out who that is that's at risk.
Transcript
Play full episode